M

Published on 22/06/2015 by admin

Filed under Complementary Medicine

Last modified 22/04/2025

Print this page

rate 1 star rate 2 star rate 3 star rate 4 star rate 5 star
Your rating: none, Average: 0 (0 votes)

This article have been viewed 1511 times

M

MARSHMALLOW

Botanical Name: Althaea officinalis
Family: Malvaceae
Plant Parts Used: Root, leaf

PRESCRIBING INFORMATION

Actions Marshmallow root and leaf:demulcent, urinary demulcent, emollient
Potential Indications

Contraindications None known. Warnings and Precautions The absorption of other medications taken simultaneously with marshmallow root may be retarded.1 Simultaneous ingestion of drug medications and marshmallow root should therefore be avoided. Interactions None known. Use in Pregnancy and Lactation No adverse effects expected. Side Effects None expected if taken within the recommended dose range. Dosage Root:   Dose per day* Dose per week*   3-6 ml of 1:5 tincture 20-40 ml of 1:5 tincture   3-6 ml of 1:5 glycetract 20-40 ml of 1:5 glycetract   Leaf:   Dose per day** Dose per week**   3-6 ml of 1:2 liquid extract 20-40 ml of 1:2 liquid extract

* This dose range is extrapolated from the British Pharmaceutical Codex 1949, the British Herbal Pharmacopoeia 1983, the British Herbal Compendium 1992, and the author’s education and experience.

** This dose range is extrapolated from the British Herbal Pharmacopoeia 1983 and the author’s education and experience.

SUPPORTING INFORMATION

Traditional Prescribing
Gastrointestinal irritation and inflammation,2 specially gastric or duodenal ulcer3
Topically for varicose ulcers,3 inflammatory lesions, swellings, wounds, bruises, and scalds2
Pharmacologic Research
The roots and leaves of marshmallow contain mucilage, consisting of acidic polysaccharides.4 Ethanol-water extracts of both marshmallow leaf and root will extract some of the mucilage in the starting herb, although mucilage is sparingly soluble in such mixtures. In the case of the root, which contains a much higher concentration of mucilage than the leaf, a glycerol-water combination is preferable for extraction given that mucilage is more soluble in this medium.
Extracts of marshmallow root demonstrated potential antiinflammatory and immunomodulatory effects in vitro,8 but lack of antiinflammatory activity was observed after oral administration of marshmallow root in carrageenan-induced rat paw edema.9 The in vivo antiinflammatory effect of an ointment containing both marshmallow root extract and dexamethasone was superior to that of the individual ingredients.10
Clinical Studies

MEADOWSWEET

Botanical Name: Filipendula ulmaria
Family: Rosaceae
Plant Part Used: Aerial parts

PRESCRIBING INFORMATION

Actions Antacid, antiinflammatory, mild urinary antiseptic, astringent
Potential Indications

Contraindications None known. Warnings and Precautions Meadowsweet contains salicylates and should be avoided or used with caution in patients with salicylate sensitivity. Interactions None known. Given the experimental anticoagulant effect, meadowsweet should be used with caution if patients are taking warfarin. Use in Pregnancy and Lactation No adverse effects expected. Side Effects None expected if taken within the recommended dose range. Dosage Dose per day* Dose per week*   3-6 ml of 1:2 liquid extract 20-40 ml of 1:2 liquid extract

* This dose range is extrapolated from the British Herbal Pharmacopoeia 1983, the British Herbal Compendium 1992, and the author’s education and experience.

SUPPORTING INFORMATION

Traditional Prescribing
Pharmacologic Research

Clinical Studies In 48 cases of cervical dysplasia treated with an ointment containing meadowsweet, a positive result was recorded in 32 patients and complete remission in 25 cases. No recurrence was observed in 10 of the completely cured patients within 12 months.

MILK THISTLE

Other Common Name: St. Mary’s thistle
Botanical Name: Silybum marianum, Carduus marianus#
Family: Compositae
Plant Part Used: Fruit (sometimes referred to as seed)

# Alternative name.

PRESCRIBING INFORMATION

Actions Hepatoprotective, hepatic trophorestorative, antioxidant, choleretic
Potential Indications

Contraindications None known. Warnings and Precautions None required. Interactions None known. Use in Pregnancy and Lactation No adverse effects expected. Side Effects Drug monitoring studies in 1995 investigating the concentrated extract (silymarin) indicated that adverse effects were recorded in 1% of patients, mainly as mild gastrointestinal complaints. A mild laxative effect was occasionally observed with milk thistle preparations. Two cases of anaphylactic shock have been reported. Dosage Dose per day* Dose per week*   4.5-8.5 ml of 1:1 liquid extract 30-60 ml of 1:1 liquid extract   4.5-8.5 ml of 1:1 glycetract 30-60 ml of 1:1 glycetract  

* This dose range is extrapolated from the German Commission E monograph.1

SUPPORTING INFORMATION

Traditional Prescribing Traditional Western herbal medicine uses include liver and gallbladder problems, including jaundice, hepatitis, and gallstones.2,3
Pharmacologic Research

Clinical Studies

MISTLETOE

Other Common Name: European mistletoe
Botanical Name: Viscum album
Family: Viscaceae
Plant Part Used: Aerial parts

PRESCRIBING INFORMATION

Actions Hypotensive, peripheral vasodilator, mild sedative
Potential Indications

Contraindications None known. Warnings and Precautions None required. Interactions None known. Use in Pregnancy and Lactation Side Effects None expected if taken within the recommended dose range. A review of data collected from 1985 to 1992 indicated that the accidental ingestion of mistletoe in the United States is not associated with profound toxicity.2 The only literature referring to side effects is for fresh mistletoe extracts given by injection. Dosage Dose per day* Dose per week*   3-6 ml of 1:2 liquid extract 20-40 ml of 1:2 liquid extract

* This dose range is extrapolated from the British Herbal Pharmacopoeia 1983 and the author’s education and experience.

SUPPORTING INFORMATION

Traditional Prescribing
Epilepsy,5 nervous excitability6

Pharmacologic Research
Dried mistletoe herb contains lectins, proteins, and polypeptides (viscotoxins), as well as polysaccharides, phenylpropanes, and lignans,7 although the constituents depend on the host tree on which the mistletoe grew, the location, and in which season it was harvested. Mistletoe extracts vary in the constituents they contain depending on the type of extract and the process used in manufacture.8 Aqueous alcoholic extracts are unlikely to contain the lectins or proteins,9 and if the viscotoxins are present, they are decomposed in the gut and not absorbed intact. (This action substantially reduces the potential toxicity of mistletoe aqueous alcoholic extracts when taken orally.)7
The results of experimental studies into the hypotensive activity of mistletoe are contradictory.7 Many studies,10,11 if not all, used administration by injection. Aqueous extracts were the most active, and a comparative study indicated that the highest activity was demonstrated by an extract of mistletoe grown on Salix spp. Suggested mechanisms of action involved inhibiting the excitability of the medulla oblongata vasomotor center and cholinomimetic activity. (This study most likely used administration by injection.)12
Clinical Studies Aqueous mistletoe extracts (which contain lectins) have been used clinically by injection for immune stimulation for many years, particularly in Europe. The concept of using fermented mistletoe extracts for cancer therapy was advocated by Rudolf Steiner in 1916. However, because these extracts or their isolated constituents were administered by injection, the results are not relevant to the clinical use of oral aqueous alcoholic extracts of mistletoe and have not been reported here.

MOTHERWORT

Botanical Name: Leonurus cardiaca
Family: Labiatae
Plant Part Used: Aerial parts

PRESCRIBING INFORMATION

Actions Nervine tonic, cardiotonic, hypotensive, antiarrhythmic, antithyroid, spasmolytic, emmenagogue
Potential Indications

Contraindications Pregnancy.1 Warnings and Precautions None required. Interactions None known. Use in Pregnancy and Lactation Contraindicated in pregnancy. Side Effects None expected if taken within the recommended dose range. Dosage Dose per day* Dose per week*   2.0-3.5 ml of 1:2 liquid extract 15-25 ml of 1:2 liquid extract

* This dose range is extrapolated from the British Herbal Pharmacopoeia 1983, the British Herbal Compendium 1992, and the author’s education and experience.

SUPPORTING INFORMATION

Traditional Prescribing
Pharmacologic Research
Clinical Studies

MULLEIN

Botanical Name: Verbascum thapsus
Family: Scrophulariaceae
Plant Part Used: Leaf

PRESCRIBING INFORMATION

Actions Expectorant, demulcent, anticatarrhal, vulnerary
Potential Indications

Contraindications None known. Warnings and Precautions None required. Interactions None known. Use in Pregnancy and Lactation No adverse effects expected. Side Effects None expected if taken within the recommended dose range. Dosage Dose per day* Dose per week*   4.5-8.5 ml of 1:2 liquid extract 30-60 ml of 1:2 liquid extract

* This dose range is extrapolated from the British Herbal Pharmacopoeia 1983 and the author’s education and experience.

MYRRH

Botanical Names: Commiphora molmol, Commiphora myrrha+
  Other species of Commiphora with comparable chemical composition may be used.
Family: Burseraceae
Plant Part Used: Resin (oleo-gum resin) obtained from the stem

+ Medicinally interchangeable species.

Interactions None known. Use in Pregnancy and Lactation Contraindicated in pregnancy. Side Effects Allergic contact dermatitis has been reported from using myrrh.2,3 For this reason, internal use should be restricted to short-term use. Dosage Dose per day* Dose per week*   1.5-4.5 ml of 1:5 tincture 10-30 ml of 1:5 tincture

* This dose range is interpreted from the British Herbal Pharmacopoeia 1983, British Pharmaceutical Codex 1934 and1973, and the author’s education and experience.

SUPPORTING INFORMATION

Traditional Prescribing
Pharmacologic Research
Myrrh increased glucose tolerance in vivo under both normal and diabetic conditions.10 Two furanosesquiterpenes isolated from myrrh exhibited hypoglycemic activity in an experimental model of diabetes.11
Petroleum ether extract of myrrh (500 mg/kg, oral route) produced significant antiinflammatory activity in carrageenan-induced inflammation and cotton pellet granuloma models. Antipyretic activity was also observed in vivo.14 Myrrh demonstrated significant antiinflammatory activity in the following experimental models:xylene-induced ear edema (400 mg/kg pretreatment by injection) and cotton pellet granuloma (400 mg/kg, oral).15
Clinical Studies

REFERENCES

1 Bensky D, Gamble A. Chinese herbal medicine materia medica. Seattle: Eastland Press, 1986.

2 Al-Suwaidan SN, et al. Contact Dermatitis. 1998;39(3):137.

3 Gallo R, et al. Contact Dermatitis. 1999;41(4):230-231.

4 British Herbal Medicine Association’s Scientific Committee. British herbal pharmacopoeia. Bournemouth: BHMA, 1983.

5 Felter HW. The eclectic materia medica, pharmacology and therapeutics. Portland: Eclectic Medical Publications, 1922. reprinted 1983

6 British Herbal Medicine Association. British herbal compendium. Bournemouth: BHMA, 1992.

7 Chopra RN, et al. Chopra’s indigenous drugs of India, ed 2. Calcutta: Academic Publishers, 1958. reprinted 1982

8 Wagner H, Bladt S. Plant drug analysis: a thin layer chromatography atlas, ed 2. Berlin: Springer-Verlag, 1996.

9 Dolara P, et al. Planta Med. 2000;66(4):356-358.

10 Al-Awadi FM, Gumaa KA. Acta Diabetol Lat. 1987;24(1):37-41.

11 Ubillas RP, et al. Planta Med. 1999;65(8):778-779.

12 Olajide OA. Phytother Res. 1999;13(3):231-232.

13 al-Harbi MM, et al. J Ethnopharmacol. 1997;55(2):141-150.

14 Tariq M, et al. Agents Actions. 1986;17(3-4):381-382.

15 Atta AH, Alkofahi A. J Ethnopharmacol. 1998;60:117-124.

16 Dolara P, et al. Nature. 1996;379(6560):29.

17 Dolara P, et al. Phytother Res. 1996;10(supp 1):S81-S83.

18 al-Harbi MM, et al. Chemotherapy. 1994;40(5):337-347.

19 Qureshi S, et al. Cancer Chemother Pharmacol. 1993;33(2):130-138.

20 al-Harbi MM, et al. Am J Chin Med. 1994;22(1):77-82.

21 Delaveau P, Lallouette P, Tessier AM. Planta Med. 1980;40(1):49-54.

22 Blumenthal M, et al, editors. The complete German Commission E monographs: therapeutic guide to herbal medicines. Austin: American Botanical Council, 1998.

23 Scientific Committee of the European Scientific Cooperative on Phytotherapy [ESCOP]. ESCOP monographs: Myrrha. Argyle House, Gandy Street, Exeter, Devon, EX4 3LS, United Kingdom: European Scientific Cooperative on Phytotherapy, ESCOP Secretariat, October 1999.